Dublin, Ireland, 19th January, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today ...

The need to allow for prognostic factors when designing and analysing cancer trials is well recognised, but the possibility of overstratification should be avoided by restricting the number of strata.

Guwahati: Researchers at the Indian Institute of Technology, Guwahati, in partnership with leading institutions around the world, have devised an innovative multi-stage clinical trial method that aims ...